92 articles
Nearly 40% of healthcare workers use unsanctioned AI tools weekly, risking a two-tier system where shadow AI harms vulnerable patients most.
Mayo Clinic's Precure Research uses AI to detect disease decades before symptoms appear, combining genetics, wearables, and environmental data in one.
Most healthcare AI tools remain stuck in labs, not clinics, a review of 108 studies finds; only a rare disease initiative shows real deployment progress.
Realistic anthropomorphic phantoms are closing the gap between AI imaging lab results and clinical performance, offering reproducible validation that.
VUMC's AI platform predicts hospital readmissions with 72% accuracy, giving clinicians an early warning system to intervene before patients return.
AI healthcare tools are multiplying fast, but regulators admit they have no roadmap yet, even as AI scribes log errors like phantom drug use.
AI drug discovery faces new global rules as the FDA, EU, and China tighten oversight, yet the AI healthcare market is still set to grow 43.9% annually.
AI is reshaping medicine so fast that doctors may never develop independent skills, forcing a urgent redefinition of clinical expertise for the AI era.
AI can now identify cancer biomarkers from routine tissue images in minutes, replacing weeks-long lab tests while preserving precious biopsy samples.
Medical AI is shifting to factory-style production, with one platform deploying 158 specialty models across 100 hospitals in just six months.
AI healthcare networks must handle 50 times more traffic within a decade, yet most hospital infrastructure was built for email, not robotic surgery or.
Medical AI is shifting from static models to autonomous AI agents that can develop and deploy tools across 5,000+ unmet imaging tasks with minimal human.
Japan's HealthTech sector is combining AI, precision engineering, and pharma partnerships to address an aging population crisis, but clinical AI error.
AI healthcare could prevent disease before it starts, but only 5% of medical AI studies use real patient data, leaving a critical gap to close.
A $35 million AI project aims to end rare disease diagnosis delays averaging six years, building the world's largest dataset across 2,700 conditions.
Huawei and Nvidia are racing to lead AI drug discovery, a market that could cut development timelines and costs in half within five years.
AI, quantum computing, and demographic pressure are reshaping American healthcare; without change, hospital margins could collapse to negative 9.6 percent.
AI can screen for hypertension and diabetes from a 5-second facial video, with 90.3% and 81.2% accuracy, using a contactless spectroscopic camera.
Yale's new medical AI master's degree trains clinicians and coders to bridge a critical gap as the global medical AI market races toward $1.2 billion.
Cigna projects $200 million in savings by using AI to detect cancer and kidney disease early, part of a broader healthcare AI shift worth $110 billion.
Brazil and Europe's AI precision medicine markets are growing at up to 31% annually, far outpacing global averages as emerging healthcare systems leapfrog.
ASTRI and Saint Francis University are teaming up to use AI to design smarter biomaterials, targeting faster drug delivery and medical device innovation.
The FTC has opened an antitrust probe into Epic Systems over patient data access and hiring practices, even as the EHR giant unveils new AI tools.
Agentic AI is automating healthcare's hidden paperwork crisis, freeing clinicians from documentation overload while reducing dangerous gaps in patient.
Lab-grown kidneys could be available by 2030, and AI is already cutting years off kidney disease trials for the 90,000 Americans awaiting transplants.
AI diagnostics now detect strokes at 98% accuracy, beating rivals by 25 points, as hospitals shift to clinical validation over vendor claims.
An AI system is denying Medicare treatments for elderly patients across six states, with approvals taking weeks instead of the promised 72 hours.
AI is now core hospital infrastructure, embedded across diagnosis, operations, and patient care as healthcare systems worldwide accelerate adoption.
Regulatory uncertainty around AI medical imaging tools is forcing radiologists to assess complex systems alone, prompting a formal FDA petition for.
Syneos Health's AI ecosystem cuts clinical trial protocol development time in half, using tools from Causaly, Databricks, and Microsoft to speed drug.
AI digital twins for cancer care can now predict immunotherapy response with 82% accuracy by merging genomic data, imaging, and real-time patient.
AI scores 92% on medical licensing exams but only 44.8% on real clinical tasks; here is what that 47-point gap means for healthcare AI deployment.
AI medical scribes are fabricating drug use and wrong diagnoses in patient records, and 40% of Australian GPs use them with little regulatory oversight.
Healthcare AI is shifting from single tasks to orchestrating entire care teams, with Hippocratic AI reporting 250 million patient interactions and zero.
The FDA has authorized over 1,400 AI medical devices, pushing manufacturers to embed governance and compliance into development from day one, not as an.
Healthcare's future lies in merging drugs, devices, and AI into unified systems, yet women's health still receives just 6% of private investment.
Twelve U.S. health systems are uniting to deploy diagnostic AI as radiologist shortages double imaging wait times, targeting faster, safer results for 20.
Leading cancer centers like MSK are building healthcare workforce pipelines through internships, residencies, and research roles spanning every career.
MSK's cancer research office has filed 99 patents and built a rare commercialization model that moves lab discoveries into patient treatments faster.
Europe is launching an AI medicine master's degree to close a critical skills gap, as demand for professionals bridging healthcare and artificial.
AI-powered breast ultrasound now detects cancers mammography misses in 40% of women with dense breasts, cutting radiologist reading time by 33%.
Ten major digital health conferences in 2026 will unite AI innovators, clinicians, and policymakers to tackle burnout, cybersecurity, and patient care.
Drug repurposing promises faster, cheaper treatments for rare diseases, but scientific, regulatory, and commercial barriers still block most candidates.
AI tools in healthcare create hidden labor burdens for clinicians, who must verify outputs, correct bias, and apply judgment that algorithms cannot.
Healthcare AI success hinges on workflow fit and clinician trust, not flashy demos, experts say; one tool already saves the NHS 85,000 hours.
Over 80% of doctors use AI, but only 8% of patients trust it; here's how "human in the loop" could close that gap in your care.
AI scribes cut physician burnout by 21%, but some doctors warn the technology can strain the patient relationship it promises to improve.
Healthcare AI could cut preventable chronic disease by 2030, with IEEE ranking health tech above all other emerging technologies for human impact.
Universities are racing to close the AI healthcare skills gap by launching bioinformatics programs that blend computer science with biology for.
Tech giants like Google and Microsoft are now building AI healthcare tools alongside hospitals, with one Mayo Clinic study cutting treatment time by 76%.
